Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, July 27, 2020
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
[ Mon, Jul 27th 2020
] - WOPRAI
Nathan Rich Initiated (AMRX) at Strong Sell and Held Target at $4 on, Jul 27th, 2020
Nathan Rich of Goldman Sachs, Initiated "Amneal Pharmaceuticals, Inc." (AMRX) at Strong Sell and Held Target at $4 on, Jul 27th, 2020.
Nathan has made no other calls on AMRX in the last 4 months.
There is 1 other peer that has a rating on AMRX. Out of the 1 peers that are also analyzing AMRX, all agrees with Nathan's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Risinger of "Morgan Stanley" Maintained at Hold with Decreased Target to $3 on, Thursday, April 2nd, 2020
Similar Stocks and Investing Articles
[ Mon, Apr 20th 2020
] - WOPRAI
[ Wed, Apr 01st 2020
] - WOPRAI
[ Fri, Feb 14th 2020
] - WOPRAI
[ Thu, Feb 13th 2020
] - WOPRAI
[ Tue, Jul 02nd 2019
] - WOPRAI
[ Tue, Jul 17th 2018
] - WOPRAI
[ Thu, Nov 09th 2017
] - WOPRAI
[ Fri, Feb 24th 2017
] - WOPRAI
[ Fri, Jul 24th 2015
] - WOPRAI